Cargando…
Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo
A TLX-5 mouse lymphoma which was resistant to 1-β-D-arabinofuranosyl cytosine (AraC) was used in vivo to study the possibility of using liposomes as drug-delivery vehicles in order to overcome drug resistance. The effects of free drugs (AraC, AraCTP and methotrexate) and the liposomally associated d...
Autores principales: | Richardson, V. J., Ryman, B. E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010977/ https://www.ncbi.nlm.nih.gov/pubmed/7073945 |
Ejemplares similares
-
Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.
por: Richardson, V. J., et al.
Publicado: (1982) -
MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001) -
Antitumour Drug-Radiation Interactions
por: Carmichael, J.
Publicado: (1992) -
Tin-based Antitumour Drugs
por: Gielen, Marcel
Publicado: (1994) -
Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
por: Kiue, A., et al.
Publicado: (1991)